QIAGEN IPA new user training
2024-10-03 13:00 - 15:00 (America/Halifax) | Virtual - Americas - EST, United States
Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries using QIAGEN IPA.
You’ll learn to:

Upload multiple dataset types (e.g., RNA-seq, proteomics, metabolomics) and perform interactive core/pathway analysis in IPA
Learn how to interpret different results, including pathways, key regulators, impact on biological functions/diseases and more
Compare different experimental conditions (e.g., single-cell clusters, disease types) and identify similarities and contrasts
Generate a network for hypothesis generation, even without a dataset or experimental design

Already have an IPA license? Install IPA and start using it now.
Learn more about IPA or request a free trial.

RNA-seq data analysis and interpretation with Sankey plot update
2024-10-07 14:00 - 15:30 UTC | Virtual - Americas - EST, United States
For RNA-seq data, you will learn how to:

Import FASTQ files, cell matrix files and metadata and how to download references
Map reads to a reference genome and generate gene and transcript counts and QC reports displaying % mapped reads, knee plots, etc.
Generate visualizations of results, such as heatmaps, differential expression tables, PCA/PCOA plots, Venn diagrams, sankey plot and others
Easily customize RNA-seq workflows
Export publication-quality graphics, tables and reports
Send differential expression tables to QIAGEN Ingenuity Pathway Analysis directly from QIAGEN CLC Genomics Workbench to analyze and interpret relevant pathways

How to triage drug targets with curated, causal relationships data
2024-10-08 13:00 - 14:00 (America/Halifax) | Virtual - Americas - EST, United States
In the rapidly evolving landscape of drug discovery, the ability to integrate high-quality research findings into knowledge graphs is paramount. For over twenty years, our scientists have curated the relationships between genes, drugs, diseases, and pathways to power Ingenuity Pathway Analysis. Now, these data are available via our QIAGEN Biomedical KB-HD, which provides direct access to flat files, SQL APIs in Python and R, and the ability to export knowledge graph objects for analysis in Neo4j. In this talk, we will explore how to use this rich data resource to:

aggregate relevant findings across our comprehensive disease and gene ontologies
cross-reference clinical trial results to focus your research on genes upstream or downstream of known drug targets
filter causal relationships by the directionality of observed effects
combine the above methods to accelerate the drug discovery process

By demonstrating the underlying database live, we will show how the high-quality curated biomedical knowledge bases can be rapidly deployed, as well as how the underlying schema and ontologies could serve as a scaffold for integrating your own research. Overall, this demonstration will show the critical role of knowledge graphs in finding viable drug targets while avoiding potential adverse outcomes and toxicity.

Webinar: Streamline your hereditary diseases interpretation workflow with QCI Interpret
2024-10-10 11:00 - 12:00 UTC | Virtual Global Event (Times shown in EST)
Learn how QCI Interpret, clinical decision support software for variant interpretation and reporting, can help your lab rapidly identify pathogenic variants, improve diagnostic yields, and significantly reduce test turnaround time for hereditary diseases. Attendees will receive a demonstration of QCI Interpret’s unique capabilities and advanced features for germline variant interpretation with example workflows for carrier screening and whole-exome sequencing panels. Key highlights will include how your lab can expedite variant interpretation by leveraging the most extensive, manually curated knowledge base, dynamically compute pathogenicity based on ACMG guidelines for every variant with full transparency, and leverage QCI Interpret’s proprietary augmented molecular intelligence approach to literature curation and variant classification to streamline your interpretation workflow.
In this webinar, attendees will:

Receive a demonstration of QCI Interpret’s analysis and interpretation workflows for hereditary diseases using targeted and extended gene panels, including whole-genome and whole-exome sequencing.
Learn about QIAGEN’s proprietary expert curation process for the knowledge base in QCI Interpret.
Explore unique time-saving features within QCI Interpret, including phenotype-driven ranking and automation of ACMG guidelines.
Understand how QCI Interpret supports copy number variant (CNV) interpretation and reporting with bibliographic coverage of over 60,000 CNV case reports.

Speaker:

Elias Hage, PhD
Associate Director, Global Product Management
QIAGEN Digital Insights

Elias Hage, PhD, is the Associate Director of Global Product Management for Hereditary Disease and Oncology Applications at QIAGEN Digital Insights (QDI). In this role, he oversees the development, management, and optimization of QDI software, databases and services for genomic analysis and interpretation of hereditary disease and oncology cases. Prior to joining QDI, Dr. Hage served as a Global Product Manager at Agilent Technologies, where he managed the Genomics division flagship SaaS application (Alissa Interpret) and supported its usage globally in both research and IVD settings. Dr. Hage obtained his Ph.D. in virology and genomics from Hannover Medical School in Belgium.

QIAGEN at VEPTC 2024
2024-10-14 - 2024-10-16 | Palermo, Italy
Meet QIAGEN at the Variant Effect Prediction Training Course (VEPTC)
This year at the 2024 Variant Effect Prediction Training Course (VEPTC), QIAGEN will be showcasing our industry-leading next-generation sequencing (NGS) variant analysis, interpretation and reporting solutions. Trusted to analyze and interpret more than 4 million NGS patient test cases, QIAGEN Clinical Insight (QCI) is the industry’s leading clinical decision support platform by volume. Find out why nobody does variant analysis and interpretation better than QIAGEN at VEPTC 2024.
Learn more and schedule a VIP meeting with our experts at VEPTC 2024 here.

Gene therapy applications through knowledge graph explorations
2024-10-16 13:00 - 15:00 (America/Halifax) | Virtual - Americas - EST, United States
In gene therapy space, there is great interest in discovering new gene editing targets as well as identifying new indications for known targets though exploration of vector biology and studying biological mechanism underlying disease pathology. In this webinar, we will focus on how recently introduced Biomedical KB-AI can enable and accelerate such investigation. QIAGEN Biomedical KB-AI uses generative AI to identify novel relationships and patterns that may be missed by traditional methods and can provide a more comprehensive view of the biological landscape. Participants will learn about:

Biomedical KB-AI and its structure
How to easily search and filter results for vector system of interest through subgraph
How to thoroughly interrogate the subgraph to look for similarity between diseases and targets that can be targeted by vectors of interest
How to effectively use knowledge graph for drug repurposing applications

Master HGMD Professional: Virtual Training Session
2024-10-16 14:00 - 15:00 UTC
Back by popular demand, our live, interactive HGMD Professional sessions are designed to help you master the skills needed to navigate and use the industry-leading database like an expert. Offered on two dates—October 16, 2024, and October 23, 2024—these virtual training sessions will show you how to effectively leverage the extensive features and functionalities of HGMD Professional compared to its public counterpart.
Attendees will learn how to:

Distinguish clinically relevant variants from variants of unknown significance (VUS)

Curate genes using HGMD Professional’s accurate, up-to-date evidence

Identify the predominant genetic variant in a specific gene to understand the genetic mechanisms underlying associated diseases

Use batch search vs advanced search when you need to query a large number of mutations or variants at once.

Can't make Session 1? Register for Session 2 on October 23 here.

Introducing the RNA-seq Analysis Portal in QIAGEN IPA
2024-10-17 13:00 - 14:30 (America/Halifax) | Virtual - Americas - EST, United States
Get to know the RNA-seq Analysis Portal, a cloud-based platform you can access from within QIAGEN Ingenuity Pathway Analysis (IPA) that helps you analyze your RNA-seq expression data. Its predefined analysis pipelines let you calculate expression levels and identify differential expression and significant pathways, regulators, diseases and functions in just a few steps. The graphical views and interactive plots enable seamless exploration and refinement of your RNA-seq analysis results.
In this training you will learn how to:

Upload your own expression data (example raw FASTQ files) or start with a public dataset
Perform RNA-seq analysis and generate outputs such as heatmap, differential expression table, volcano plot and more
Export graphical and tabular results

Learn more about the IPA RNA-seq Analysis Portal.

Master HGMD Professional: Virtual Training Session
2024-10-23 10:00 - 11:00 UTC
Back by popular demand, our live, interactive HGMD Professional sessions are designed to help you master the skills needed to navigate and use the industry-leading database like an expert. This virtual training session will show you how to effectively leverage the extensive features and functionalities of HGMD Professional compared to its public counterpart.
Attendees will learn how to:

Distinguish clinically relevant variants from variants of unknown significance (VUS)

Curate genes using HGMD Professional’s accurate, up-to-date evidence

Identify the predominant genetic variant in a specific gene to understand the genetic mechanisms underlying associated diseases
Use batch search vs advanced search when you need to query a large number of mutations or variants at once.

2024 update: Long reads analysis with QIAGEN CLC Genomics Workbench
2024-10-24 13:00 - 14:30 (America/Halifax) | Virtual - Americas - EST, United States
This webinar will introduce users to the long read support plugin for Oxford Nanopore and PacBio sequencing reads in QIAGEN CLC Genomics Workbench.
Participants will learn how to:

Download and install needed plugins
Import data required for the analysis
Perform long read de novo assembly
Map reads to a reference and visualize an assembly
Use BLAST to investigate the contigs
Use additional long read tools: polish with short reads, structural variant calling
Use genome finishing tools: analyze and assemble contigs
Use analytical tools: RNA-seq analysis for long reads, classify long read amplicons for metagenomics

QIAGEN at the Precision Medicine Forum Berlin
2024-10-29 - 2024-10-30 | Berlin, Germany
Meet QIAGEN at the Precision Medicine Forum Berlin
This year at the 2024 Precision Medicine Forum Berlin, QIAGEN will showcase our barrier-breaking Sample to Insight Oncology solution. Combining targeted DNA and multimodal pan-cancer panels, one of the fastest and cheapest secondary analysis solutions in the market, and industry-leading variant interpretation and reporting software trusted to analyze and interpret over 4 million NGS patient test cases worldwide, our Sample to Insight Oncology solution is revolutionizing precision oncology testing.
Learn more and register here.

QIAGEN at ASHG 2024
2024-11-05 - 2024-11-09
Meet QIAGEN at the 2024 American Society of Human Genetics (ASHG) Annual Meeting
This year at the 2024 American Society of Human Genetics (ASHG) Annual Meeting, QIAGEN will showcase our Sample to Insight solutions for human genetics and inherited disease applications. From digital PCR technologies and actionable exome panels to one of the fastest and cheapest secondary analysis solutions in the market and industry-leading variant interpretation and reporting software trusted to analyze and interpret over 4 million NGS patient test cases worldwide, our Sample to Insight solutions are revolutionizing genetic testing.
Learn more and schedule a VIP meeting with our experts at ASHG 2024 here.

QIAGEN IPA new user training
2024-11-06 13:00 - 15:00 UTC | Virtual - Americas - EST, United States
Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries using QIAGEN IPA.
You’ll learn how to:

Upload multiple dataset types (e.g., RNA-seq, proteomics, metabolomics) and perform interactive core/pathway analysis in IPA
Interpret different results, including pathways, key regulators, impact on biological functions/diseases and more
Compare different experimental conditions (e.g., single-cell clusters, disease types) and identify similarities and contrasts
Generate a network for hypothesis generation, even without a dataset or experimental design

Already have an IPA license? Install IPA and start using it now.
Learn more about IPA or request a free trial.

Exclusive Interactive Workshop: Master Clinical Variant Interpretation with QCI Interpret for Oncology
2024-11-07 11:00 - 13:00 UTC
An exclusive hands-on workshop to try QCI Interpret for Oncology
For US-based labs interested in learning more about QCI Interpret for Oncology, QIAGEN’s clinical decision support software for variant interpretation and reporting, we are hosting an exclusive, interactive virtual workshop where you can access and demo the software for free. Each attendee will be given a temporary license and a VCF file to run a case on the industry-leading software. Through a guided session, you will be able to see first-hand how QCI Interpret works, with full exploration of the software’s capabilities and features.
In this workshop, you will see how QCI Interpret:
• Dynamically computes pathogenicity and actionability based on the ACMG and AMP/ASCO/CAP guidelines for every variant in all cancer types with full transparency.
• Provides access to over 500,000 pre-formulated, oncologist-reviewed variant interpretation summaries to build customizable, oncologist-ready reports.
• Effortlessly streamlines case reviews by automatically selecting reportable variants, along with tailored treatments and trials.
Only 40 spots available. Must apply by October 25, 2024.
This workshop is an exclusive event limited to a select number of participants. To register, you must provide a work email and be selected by QIAGEN to attend. The workshop will be hosted on a US server and no customer data will be involved.
Learn more and register here.

Support Session for IPA Certification
2024-11-07 13:00 - 14:30 (Asia/Dubai) | Virtual - Americas - EST, United States
Join us for a 90-minute LIVE group session designed to address different technical questions regarding IPA certification. QIAGEN IPA scientists will answer different IPA related technical questions and clarify various topics per requests of IPA certification participants. If possible, please register for this session and let us know your questions by November 4, 2024.
Please note:

We strongly encourage you to submit your questions ahead of time through this registration form.
While questions submitted through this registration ahead of time will be prioritized, we will try to answer as many questions as possible in these 90 min.
The purpose of this session is NOT for QIAGEN scientist to answer IPA certification exam questions but rather explain concepts surrounding these questions. Example, for exam question asking how many molecules are mapped vs unmapped in the exam dataset, the QIAGEN scientist will not give you the number but if asked, will go over relevant steps of the data upload process.
Only those who signed up for IPA certification are invited to this session.

Questions we have so far:

Explain course structure and exam related details.
Go over recent update (RNA-seq analysis portal, new pathways, GWAS etc.) and cover this in context of this course.

Discover biomarkers, validate targets and identify variants with QDI software
2024-11-12 13:00 - 14:30 (America/Halifax) | Virtual - Americas - EST, United States
Learn how to leverage solutions from QIAGEN Digital Insights to discover biomarkers, validate targets, and identify variants.
Attendees will learn to:

Locate public studies of interest using OmicSoft DiseaseLand
Investigate expression of genes of interest across different treatments, disease states, etc.
Identify variants of interest for candidate biomarkers and targets using Human Gene Mutation Database (HGMD)
Leverage the QIAGEN Knowledgebase in Ingenuity Pathway Analysis (IPA) to explore and extend findings from OmicSoft DiseaseLand and HGMD
Access data from OmicSoft, HGMD and IPA in ways that are helpful for data scientists

Webinar: Pharmacogenomics - One tool to decode drug response to variation in the genome
2024-11-13 10:00 - 11:00 (America/New_York)
Each year, more than 134 million patients experience adverse drug events, causing 2.4 million deaths worldwide. What if there was a better way to develop and prescribe safer, more effective drugs based on the unique genetic information of every individual?
In this webinar, learn about a game-changing solution for labs and pharmaceutical companies to rapidly and confidently translate complex pharmacogenomics (PGx) data into evidence-backed insights to inform therapeutic outcomes. QIAGEN Pharmacogenomic Insights (PGXI) is a new expert-curated knowledgebase solution that provides comprehensive access to verified and up-to-date data from multiple PGx sources, including the FDA, CPIC, DPWG, PharmVar, and PubMed. Built upon a legacy platform used to deliver more than 1.6 million PGx annotations for more than 250 clinical research laboratories, PGXI seamlessly integrates into existing or new workflows to automate the annotation of PGx data from all platforms, including NGS and arrays. Within minutes, users can retrieve a custom output of relevant information, including relevant conditions associated with queried genes of interest, relevant drug-gene associations, and curated literature evidence for alleles in question.
In this webinar, you will learn:

How PGXI can help your lab efficiently and consistently identify medications associated with adverse effects.
What expert-curated content sources are available in PGXI, eliminating the need to consult multiple databases and saving you significant time and money.
How to use PGXI to seamlessly scale your PGXI workflow and stay at the cutting edge of PGx research.

Plus, if eligible, webinar attendees can try PGXI for free with an exclusive trial offer from QIAGEN. There’s an easier and faster way to translate PGx data into insights. Don’t miss this opportunity to elevate and transform your PGx program.
Learn more and register here.

Checkpoint inhibitor and immuno-oncology investigation leveraging curated high-quality public ‘omics data
2024-11-14 13:00 - 14:30 (America/Halifax) | Virtual - Americas - EST, United States
While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data, such investigation is hindered by the difficulty in finding and combining related datasets to perform large-scale meta-analyses. This webinar will focus on how high-quality curated genomic repositories such as QIAGEN OmicSoft Lands immediately allows in-depth investigations across diverse data sources (GEO, CPTAC, TCGA, GTEx and more) to discover and validate candidate checkpoint inhibitor drug targets and biomarkers.
You will learn how to do the following in the graphical user interface and through APIs:

Easily identify relevant samples using extensive manually curated clinical metadata
Visualize and identify checkpoint inhibition biology-related drug target and biomarkers expression patterns using expression data (RNA-seq, scRNA-seq, proteomics etc.)
Reveal how the expression of a group of biomarkers (or genes/proteins of interest) correlates in normal and disease tissue

QIAGEN at AMP 2024
2024-11-19 08:00 - 2024-11-23 17:00 UTC
Meet QIAGEN at the 2024 Association for Molecular Pathology (AMP) Annual Meeting
This year at the 2024 Association for Molecular Pathology (AMP) Annual Meeting, QIAGEN will showcase our barrier-breaking Sample to Insight Oncology solution. Combining targeted DNA and multimodal pan-cancer panels, one of the fastest and cheapest secondary analysis solutions in the market, and industry-leading variant interpretation and reporting software trusted to analyze and interpret over 4 million NGS patient test cases worldwide, our Sample to Insight Oncology solution is revolutionizing precision oncology testing.
Lean more and schedule a VIP meeting with our experts at AMP 2024 here.

Investigating genomic variants using QIAGEN CLC Genomics Workbench, QCI Interpret-Translational (QCII-T), and Ingenuity Pathway Analysis (IPA)
2024-11-19 13:00 - 14:30 (Asia/Dubai) | Virtual - Americas - EST, United States
Discovery of new genes implicated in hereditary diseases or cancer progression is challenging and advancing rapidly with an increase in the amount of cohort data to analyze from next generation sequencing (NGS) data to associations between gene variants and diseases, and finally to biological mechanisms of these gene variants. Combining QIAGEN CLC Genomics Workbench, QCII-T, and IPA, scientists can analyze sequencing data obtained from a variety of NGS technologies, annotate gene variants using the world’s most comprehensive and up-to-date curated scientific evidence, and find biological connections in gene variants with manually curated scientific findings. Get valuable and reliable insights for your research project and speed up your discoveries by using a streamlined NGS analysis workflow.
In this webinar, attendees will have the opportunity to:

Learn how to import whole genome or exome sequencing data into QIAGEN CLC Genomics Workbench and use the ultra-fast LightSpeed Module that delivers end-to-end NGS FASTQ to VCF pipeline;
Explore capabilities in QCII-T which can enable scientists to accelerate discoveries from hereditary or tumor cohort analyses to find associations between gene variants and diseases;
Learn how to use IPA and its manually curated content among other integrated scientific evidence to uncover novel biological mechanisms underlying these gene variants.

New feature: Insights with IPA Interpret
2024-11-20 13:00 - 14:00 (Asia/Dubai) | Virtual - Americas - EST, United States
Unlock actionable insights in your biological data by streamlining your data interpretation with IPA Interpret.
The newest feature of your trusted pathway analysis software, QIAGEN IPA, includes:

Content powered by IPA's extensive, manually curated knowledge base and aided by AI
Easy-to-share reports and updated visualizations to facilitate collaboration and dissemination of research findings
Easy access from your favorite web browser, no additional software or hardware needed

New feature: Navigating datasets with OmicSoft Explorer
2024-11-21 13:00 - 14:00 (Asia/Dubai)
Meet OmicSoft Explorer, a new feature included with your QIAGEN IPA/OmicSoft subscriptions. See how you can find ‘omics datasets to inform your next experiments or support your grant proposals.
With OmicSoft Explorer, you can:

Search over 10,000 disease-relevant datasets for clinical, in vitro, normal tissue and more
Reveal top differentially expressed genes from over 200,000 experiments
Discover experiments that include your gene of interest
Explore underlying biology through IPA Interpret

QIAGEN IPA new user training
2025-01-07 13:00 - 15:00 (America/New_York) | Virtual - Americas - EST, United States
Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries using QIAGEN IPA.
You’ll learn to:

Upload multiple dataset types (e.g., RNA-seq, proteomics, metabolomics) and perform interactive core/pathway analysis in IPA
Learn how to interpret different results, including pathways, key regulators, impact on biological functions/diseases and more
Compare different experimental conditions (e.g., single-cell clusters, disease types) and identify similarities and contrasts
Generate a network for hypothesis generation, even without a dataset or experimental design

Already have an IPA license? Install IPA and start using it now.
Learn more about IPA or request a free trial.
Register for the event.

Support Session for IPA Certification
2025-01-09 13:00 - 14:30 (America/New_York) | Virtual - Americas - EST, United States
Join us for a 90-minute LIVE group session designed to address different technical questions regarding IPA certification. QIAGEN IPA scientists will answer different IPA related technical questions and clarify various topics per requests of IPA certification participants.

Please note:

We strongly encourage you to submit your questions ahead of time through this registration form.
While questions submitted through this registration ahead of time will be prioritized, we will try to answer as many questions as possible in these 90 min.
The purpose of this session is NOT for QIAGEN scientist to answer IPA certification exam questions but rather explain concepts surrounding these questions. For example, if you ask how many molecules are mapped vs unmapped in the exam dataset, the QIAGEN scientist will go over relevant steps of the data upload process rather than give you the number directly.
Only those who signed up for IPA certification are invited to this session.
Questions we have so far:

Explain course structure and exam related details.

Go over recent update (RNA-seq analysis portal, new pathways, GWAS etc.) and cover this in context of this course.

Register for the event.

Sanger sequencing, alignment, cloning, primer design and more using QIAGEN CLC Main and Genomics Workbench
2025-01-14 13:00 - 14:30 (America/New_York) | Virtual - Americas - EST, United States
This training will be relevant to both QIAGEN Main and Genomics workbench users and prospects who are interested in below analytics.

Alignment and tree construction
Sanger sequencing analysis
Cloning and primer design
Other molecular biology tools

Register for the event.

Discoveries from deeply curated TCGA expression data using OmicSoft Studio
2025-01-16 13:00 - 14:30 (America/New_York) | Virtual - Americas - EST, United States
While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data sources such as The Cancer Genome Atlas (TCGA), such investigation is hindered by difficulties in finding and combining related datasets to perform large-scale meta-analyses. This webinar will focus on how high-quality curated genomic repositories such as QIAGEN OmicSoft Lands immediately allows in-depth investigations across diverse data sources (GEO, CPTAC, TCGA, GTEx and more) to discover and validate candidate checkpoint inhibitor drug targets and biomarkers.
You will discover how to:

Use sample IDs to create a custom dataset from the deeply curated TCGA collection available within OmicSoft Lands
Easily download count information for each sample across all genes and create a local or server project
Calculate differential expression using metadata of interest
Generate volcano, PCA/PCOA, heatmap, expression and other plots for scientific discoveries
Upload the data to Ingenuity Pathway Analysis for hypothesis generation

Register for the event.

Single-cell RNA-seq, cell hashing and spatial transcriptomics
2025-01-20 14:00 - 15:30 (America/New_York) | Virtual - Americas - EST, United States
In this training, you will learn how to analyze and interpret your own single cell RNA-seq data using QIAGEN CLC Genomics Workbench starting with either FASTQ or matrix files.
Using CLC Genomics Workbench, you will learn how to perform secondary analysis on your single cell RNA-seq data. Specifically, you will learn how to:

Import your raw FASTQ or processed cell-matrix files.
Use pre-configured but customizable pipelines/workflows for single cell RNA-seq data.
Generate high resolution visuals and other files from your analysis for publications and biopharmaceutical discoveries, including dimension reduction (UMAP, t-SNE) plots, differential expression table for clusters, cell types or both, heat maps, dot plots and violin plots.
Learn how to use “Create Cell Annotations from Hashtags” for cell hashing (i.e., CITE-seq).
Dive into spatial transcriptomic analysis, the latest feature in the single cell RNA-seq module.

Register for the event.

Identifying critical drug-to-disease pathways using high-quality curated literature and ‘omics data
2025-01-21 13:00 - 14:00 (America/New_York) | Virtual - Americas - EST, United States
In the drug discovery pipeline, evaluating multiple pathways between a drug target and disease is crucial for identifying potential therapeutic approaches. By examining overlapping pathways between competing drugs, researchers can uncover novel drug targets, while isoform-specific findings may elucidate unexpected clinical trial outcomes. Filtering these pathways with real-world expression and proteomics data is essential to validate new hypotheses and avoid pursuing non-viable leads.
Leveraging tools such as Neo4j, Python, and R, powered by curated databases like the QIAGEN Biomedical Knowledge Base and OmicSoft Lands, enables scientists to efficiently explore potential mechanisms of action during both target discovery and later stages of drug development.
Attendees will learn to:

Apply pathfinding algorithms to navigate our comprehensive knowledge graph.
Qualify drug candidates using curated scRNA-Seq expression data and detailed cell type annotations.
Expand, filter, prioritize, and refine lists of biomarkers and drug targets through various advanced approaches.

Register for the event.

Tissue-specific target identification using QIAGEN OmicSoft high-quality ‘omics data
2025-01-23 13:00 - 14:00 (America/New_York) | Virtual - Americas - EST, United States
Disease pathogenesis is often context-dependent, specifically on tissue expression profiles within a given disease context. However, tissue expression profile of drug targets or potential targets is often difficult to ascertain. In this webinar, we will dive deep into the wealth of available deeply curated high quality ‘omics data (RNA-seq, scRNA-seq and more) in the OmicSoft Lands database using APIs to achieve the following:

Demonstrate how to obtain a disease gene signature of interest.
Compare the constitutive expression profile of that gene set across different tissues.
Find tissues with similar expression profiles.
Generate a hypothesis relating two tissue specific diseases to each other for the purpose of indication expansion.

Register for the event.

Test event 1
2025-08-31 08:00 - 17:00 UTC
Some quick page content so we can see the difference in output.
